The content is available as a PDF (336.8 KB).
Footnotes
Todos los autores de este artículo han colaborado ocasionalmente, de forma directa o indirecta, a través de la Fundació Atenció Primària, con algunos de los laboratorios productores de los fármacos que aparecen en el informe
Bibliografía
- 1.The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Rearch Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. Jama. 2002;288:2981–2987. doi: 10.1001/jama.288.23.2981. [DOI] [PubMed] [Google Scholar]
- 2.The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–2446. doi: 10.1001/archinte.157.21.2413. [DOI] [PubMed] [Google Scholar]
- 3.Wing L., Reid C., Ryan P., Beilin L.J., Brown M.A., Jennings G., for the Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensinconverting- enzyme inhibitors and diuretics. N Engl J Med. 2003;348:583–592. doi: 10.1056/NEJMoa021716. [DOI] [PubMed] [Google Scholar]